Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 19 | 2022 | 755 | 3.280 |
Why?
|
Glioma | 11 | 2022 | 280 | 2.520 |
Why?
|
Muscle, Skeletal | 14 | 2018 | 441 | 1.590 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 447 | 1.300 |
Why?
|
Brain | 9 | 2021 | 2206 | 1.130 |
Why?
|
Autopsy | 5 | 2021 | 112 | 1.120 |
Why?
|
Neuroblastoma | 7 | 2021 | 365 | 1.100 |
Why?
|
Muscular Diseases | 5 | 2018 | 60 | 1.080 |
Why?
|
Mutation | 13 | 2022 | 3904 | 0.960 |
Why?
|
Myasthenic Syndromes, Congenital | 6 | 2021 | 35 | 0.920 |
Why?
|
Alzheimer Disease | 4 | 2017 | 445 | 0.910 |
Why?
|
Humans | 103 | 2022 | 84493 | 0.900 |
Why?
|
Peripheral Nervous System Diseases | 3 | 2020 | 83 | 0.880 |
Why?
|
Central Nervous System Neoplasms | 3 | 2020 | 80 | 0.850 |
Why?
|
Megakaryocytes | 1 | 2021 | 36 | 0.840 |
Why?
|
Biopsy | 6 | 2022 | 1144 | 0.840 |
Why?
|
Telomerase | 1 | 2021 | 55 | 0.840 |
Why?
|
Placenta | 2 | 2022 | 169 | 0.830 |
Why?
|
Microvessels | 1 | 2021 | 68 | 0.810 |
Why?
|
Acute Lung Injury | 1 | 2021 | 60 | 0.790 |
Why?
|
Immunohistochemistry | 14 | 2022 | 1747 | 0.750 |
Why?
|
Pathology, Surgical | 1 | 2019 | 12 | 0.740 |
Why?
|
Microbiological Techniques | 1 | 2019 | 24 | 0.740 |
Why?
|
Biomarkers, Tumor | 7 | 2022 | 1450 | 0.730 |
Why?
|
Cerebellar Neoplasms | 3 | 2017 | 35 | 0.700 |
Why?
|
Rhabdoid Tumor | 2 | 2016 | 19 | 0.680 |
Why?
|
Pathology, Clinical | 1 | 2018 | 33 | 0.680 |
Why?
|
Schwann Cells | 3 | 2020 | 34 | 0.680 |
Why?
|
Neurilemmoma | 2 | 2021 | 34 | 0.660 |
Why?
|
Hemangioblastoma | 2 | 2017 | 12 | 0.650 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2017 | 7 | 0.640 |
Why?
|
Male | 48 | 2021 | 40460 | 0.640 |
Why?
|
Adaptor Proteins, Signal Transducing | 7 | 2018 | 300 | 0.640 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 38 | 0.640 |
Why?
|
Pheochromocytoma | 1 | 2017 | 46 | 0.620 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2013 | 424 | 0.620 |
Why?
|
Neoplasms | 2 | 2022 | 2809 | 0.610 |
Why?
|
Glioblastoma | 4 | 2015 | 249 | 0.610 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2017 | 77 | 0.600 |
Why?
|
Muscular Dystrophies | 4 | 2013 | 53 | 0.590 |
Why?
|
Glycogen Debranching Enzyme System | 1 | 2016 | 3 | 0.580 |
Why?
|
Glycogen Storage Disease | 1 | 2016 | 5 | 0.580 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 532 | 0.580 |
Why?
|
Female | 51 | 2022 | 43911 | 0.570 |
Why?
|
Myoepithelioma | 1 | 2015 | 11 | 0.560 |
Why?
|
Soft Tissue Neoplasms | 3 | 2020 | 126 | 0.560 |
Why?
|
Myofibrils | 2 | 2014 | 22 | 0.550 |
Why?
|
Niemann-Pick Disease, Type C | 1 | 2015 | 3 | 0.540 |
Why?
|
Lymphoproliferative Disorders | 1 | 2015 | 106 | 0.530 |
Why?
|
Nerve Sheath Neoplasms | 3 | 2020 | 17 | 0.530 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 427 | 0.530 |
Why?
|
Complement C4 | 1 | 2014 | 9 | 0.530 |
Why?
|
Nervous System Diseases | 1 | 2016 | 151 | 0.530 |
Why?
|
Complement Membrane Attack Complex | 1 | 2014 | 20 | 0.520 |
Why?
|
Sella Turcica | 2 | 2019 | 17 | 0.520 |
Why?
|
Middle Aged | 29 | 2022 | 24751 | 0.520 |
Why?
|
Myositis | 1 | 2014 | 16 | 0.520 |
Why?
|
Vesicular Transport Proteins | 4 | 2018 | 63 | 0.520 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 102 | 0.520 |
Why?
|
Astrocytoma | 3 | 2022 | 82 | 0.510 |
Why?
|
Pituitary Neoplasms | 2 | 2019 | 62 | 0.510 |
Why?
|
Muscle Proteins | 7 | 2014 | 133 | 0.490 |
Why?
|
Temporal Lobe | 1 | 2015 | 170 | 0.490 |
Why?
|
Carbonic Anhydrases | 1 | 2014 | 15 | 0.490 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2014 | 42 | 0.480 |
Why?
|
Membrane Proteins | 9 | 2015 | 1181 | 0.480 |
Why?
|
Paraganglioma | 2 | 2019 | 16 | 0.450 |
Why?
|
Seizures | 1 | 2015 | 290 | 0.440 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 99 | 0.440 |
Why?
|
Aged, 80 and over | 11 | 2021 | 6457 | 0.430 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 394 | 0.430 |
Why?
|
Gene Expression Regulation | 4 | 2017 | 1894 | 0.420 |
Why?
|
Organ Transplantation | 1 | 2015 | 262 | 0.420 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 323 | 0.420 |
Why?
|
Neurofibromatosis 1 | 2 | 2022 | 36 | 0.410 |
Why?
|
Hippocampus | 1 | 2015 | 441 | 0.410 |
Why?
|
Adolescent | 11 | 2021 | 8849 | 0.400 |
Why?
|
Aged | 19 | 2021 | 18159 | 0.390 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2009 | 19 | 0.380 |
Why?
|
Adult | 24 | 2021 | 25287 | 0.370 |
Why?
|
Cardiomyopathies | 4 | 2021 | 237 | 0.370 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2017 | 182 | 0.370 |
Why?
|
Pneumocephalus | 1 | 2009 | 9 | 0.370 |
Why?
|
Embolism, Air | 1 | 2009 | 21 | 0.370 |
Why?
|
Nervous System Neoplasms | 1 | 2009 | 11 | 0.370 |
Why?
|
Central Nervous System Bacterial Infections | 1 | 2009 | 1 | 0.370 |
Why?
|
Retrospective Studies | 7 | 2021 | 8152 | 0.350 |
Why?
|
Transcription Factors | 4 | 2022 | 1511 | 0.350 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2008 | 4 | 0.350 |
Why?
|
World Health Organization | 1 | 2009 | 102 | 0.350 |
Why?
|
Craniopharyngioma | 1 | 2009 | 11 | 0.350 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 1059 | 0.350 |
Why?
|
Antineoplastic Agents, Alkylating | 3 | 2018 | 138 | 0.340 |
Why?
|
Diagnosis, Differential | 8 | 2021 | 1536 | 0.340 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2008 | 10 | 0.340 |
Why?
|
Ventricular Fibrillation | 1 | 2008 | 65 | 0.340 |
Why?
|
Nerve Tissue Proteins | 6 | 2018 | 502 | 0.340 |
Why?
|
Child, Preschool | 10 | 2021 | 3578 | 0.340 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2008 | 67 | 0.340 |
Why?
|
Laminin | 3 | 2018 | 83 | 0.330 |
Why?
|
Child | 12 | 2021 | 6776 | 0.330 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2009 | 102 | 0.330 |
Why?
|
Mice | 29 | 2020 | 11056 | 0.330 |
Why?
|
Oligodendroglia | 2 | 2020 | 123 | 0.320 |
Why?
|
Hemorrhage | 1 | 2009 | 249 | 0.320 |
Why?
|
Disease Models, Animal | 10 | 2016 | 2208 | 0.310 |
Why?
|
Nuclear Proteins | 4 | 2016 | 688 | 0.310 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2007 | 21 | 0.300 |
Why?
|
Dacarbazine | 3 | 2013 | 102 | 0.300 |
Why?
|
rho-Associated Kinases | 2 | 2019 | 159 | 0.290 |
Why?
|
Dementia, Vascular | 1 | 2006 | 6 | 0.290 |
Why?
|
Animals | 34 | 2020 | 26197 | 0.290 |
Why?
|
Spinal Diseases | 1 | 2006 | 45 | 0.280 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 386 | 0.280 |
Why?
|
Sepsis | 1 | 2009 | 288 | 0.280 |
Why?
|
DNA-Binding Proteins | 3 | 2020 | 1202 | 0.280 |
Why?
|
Cerebral Infarction | 1 | 2006 | 67 | 0.270 |
Why?
|
Ganglioneuroma | 1 | 2005 | 9 | 0.270 |
Why?
|
Cauda Equina | 1 | 2005 | 13 | 0.270 |
Why?
|
Liposarcoma | 1 | 2005 | 10 | 0.270 |
Why?
|
Amyloid Neuropathies, Familial | 2 | 2017 | 25 | 0.270 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 2 | 2019 | 211 | 0.260 |
Why?
|
Dura Mater | 2 | 2020 | 44 | 0.260 |
Why?
|
Infant | 8 | 2020 | 3003 | 0.260 |
Why?
|
Neuromuscular Junction | 3 | 2021 | 80 | 0.260 |
Why?
|
ErbB Receptors | 2 | 2021 | 481 | 0.250 |
Why?
|
Young Adult | 6 | 2021 | 5883 | 0.250 |
Why?
|
Amyloid beta-Peptides | 2 | 2021 | 192 | 0.250 |
Why?
|
Stress, Physiological | 2 | 2020 | 226 | 0.240 |
Why?
|
Magnetic Resonance Imaging | 12 | 2020 | 3351 | 0.240 |
Why?
|
Myoblasts | 4 | 2014 | 29 | 0.240 |
Why?
|
Motor Neurons | 2 | 2017 | 159 | 0.240 |
Why?
|
Cell Count | 2 | 2021 | 193 | 0.240 |
Why?
|
Fatal Outcome | 5 | 2013 | 290 | 0.230 |
Why?
|
Myocardium | 3 | 2018 | 523 | 0.230 |
Why?
|
Lymphoma | 2 | 2018 | 259 | 0.230 |
Why?
|
Vasculitis | 2 | 2020 | 38 | 0.230 |
Why?
|
Spinal Nerve Roots | 1 | 2002 | 17 | 0.230 |
Why?
|
Neurofibromatoses | 1 | 2002 | 9 | 0.230 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2002 | 10 | 0.230 |
Why?
|
Tissue Fixation | 1 | 2022 | 40 | 0.220 |
Why?
|
Paraffin Embedding | 1 | 2022 | 78 | 0.220 |
Why?
|
Formaldehyde | 1 | 2022 | 52 | 0.220 |
Why?
|
Lambert-Eaton Myasthenic Syndrome | 2 | 2021 | 2 | 0.220 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 928 | 0.220 |
Why?
|
Monosomy | 1 | 2022 | 12 | 0.220 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2022 | 6 | 0.220 |
Why?
|
Muscle Development | 2 | 2014 | 41 | 0.210 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2021 | 6 | 0.210 |
Why?
|
Chondrosarcoma | 1 | 2022 | 48 | 0.210 |
Why?
|
Specimen Handling | 1 | 2022 | 96 | 0.210 |
Why?
|
Synaptotagmin II | 1 | 2021 | 1 | 0.210 |
Why?
|
Chloroquine | 1 | 2021 | 12 | 0.210 |
Why?
|
Hydroxychloroquine | 1 | 2021 | 10 | 0.210 |
Why?
|
Cystadenoma, Papillary | 1 | 2021 | 8 | 0.210 |
Why?
|
Antimalarials | 1 | 2021 | 18 | 0.210 |
Why?
|
Pelvic Neoplasms | 2 | 2012 | 44 | 0.210 |
Why?
|
Workflow | 1 | 2021 | 74 | 0.210 |
Why?
|
Tissue Array Analysis | 2 | 2013 | 124 | 0.200 |
Why?
|
Quinine | 1 | 2001 | 5 | 0.200 |
Why?
|
Cobalt | 1 | 2001 | 29 | 0.200 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2019 | 199 | 0.200 |
Why?
|
Axons | 2 | 2020 | 172 | 0.200 |
Why?
|
ELAV-Like Protein 1 | 1 | 2020 | 2 | 0.200 |
Why?
|
Visual Prosthesis | 1 | 2020 | 5 | 0.200 |
Why?
|
Osteosarcoma | 1 | 2022 | 159 | 0.190 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 2019 | 36 | 0.190 |
Why?
|
Neuropathology | 1 | 2020 | 3 | 0.190 |
Why?
|
Blood Platelets | 1 | 2021 | 149 | 0.190 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 1063 | 0.190 |
Why?
|
Sarcoma | 2 | 2017 | 210 | 0.190 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2020 | 13 | 0.190 |
Why?
|
RNA-Binding Protein FUS | 1 | 2020 | 11 | 0.190 |
Why?
|
Spinal Cord Diseases | 1 | 2020 | 29 | 0.190 |
Why?
|
Deltoid Muscle | 1 | 2020 | 2 | 0.190 |
Why?
|
Respiratory Tract Infections | 1 | 2021 | 104 | 0.190 |
Why?
|
Smooth Muscle Tumor | 1 | 2020 | 4 | 0.190 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2020 | 72 | 0.190 |
Why?
|
Organometallic Compounds | 1 | 2001 | 128 | 0.190 |
Why?
|
Simvastatin | 2 | 2019 | 106 | 0.190 |
Why?
|
Tumor Suppressor Proteins | 3 | 2016 | 277 | 0.180 |
Why?
|
Fasciitis | 1 | 2019 | 9 | 0.180 |
Why?
|
Synaptic Transmission | 2 | 2018 | 220 | 0.180 |
Why?
|
Myosin Heavy Chains | 4 | 2019 | 88 | 0.180 |
Why?
|
Mucolipidoses | 1 | 2019 | 3 | 0.180 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2010 | 114 | 0.180 |
Why?
|
Transferases (Other Substituted Phosphate Groups) | 1 | 2019 | 11 | 0.180 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2020 | 47 | 0.180 |
Why?
|
Frozen Sections | 1 | 2019 | 48 | 0.180 |
Why?
|
Mice, Transgenic | 8 | 2017 | 1519 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 370 | 0.180 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2020 | 78 | 0.180 |
Why?
|
Orbital Diseases | 1 | 2019 | 21 | 0.180 |
Why?
|
Lung Neoplasms | 2 | 2009 | 2235 | 0.180 |
Why?
|
Herpesvirus 4, Human | 1 | 2020 | 111 | 0.180 |
Why?
|
TDP-43 Proteinopathies | 1 | 2019 | 8 | 0.180 |
Why?
|
Optic Chiasm | 1 | 2019 | 16 | 0.180 |
Why?
|
Protein Aggregation, Pathological | 1 | 2018 | 8 | 0.180 |
Why?
|
Bone Neoplasms | 1 | 2022 | 322 | 0.170 |
Why?
|
Theilovirus | 1 | 2019 | 39 | 0.170 |
Why?
|
Amyloidosis | 1 | 2020 | 103 | 0.170 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 307 | 0.170 |
Why?
|
Carcinogenesis | 1 | 2020 | 190 | 0.170 |
Why?
|
Postoperative Complications | 1 | 2008 | 2172 | 0.170 |
Why?
|
Motor Cortex | 2 | 2017 | 190 | 0.170 |
Why?
|
Brain Diseases | 1 | 2019 | 177 | 0.170 |
Why?
|
Inflammation | 3 | 2014 | 882 | 0.170 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2020 | 259 | 0.160 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2018 | 112 | 0.160 |
Why?
|
Influenza, Human | 1 | 2021 | 327 | 0.160 |
Why?
|
Necrosis | 3 | 2014 | 196 | 0.160 |
Why?
|
Motor Endplate | 2 | 2018 | 31 | 0.160 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2015 | 44 | 0.160 |
Why?
|
Cell Line, Tumor | 7 | 2020 | 2395 | 0.160 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 111 | 0.160 |
Why?
|
Pregnancy | 2 | 2022 | 2820 | 0.160 |
Why?
|
Visual Cortex | 1 | 2020 | 222 | 0.160 |
Why?
|
Multiple Sclerosis | 1 | 2020 | 259 | 0.160 |
Why?
|
Stem Cell Transplantation | 2 | 2016 | 183 | 0.160 |
Why?
|
Cohort Studies | 3 | 2021 | 2719 | 0.160 |
Why?
|
Neuromuscular Junction Diseases | 1 | 2017 | 3 | 0.160 |
Why?
|
Carrier Proteins | 3 | 2010 | 664 | 0.160 |
Why?
|
Survival Analysis | 4 | 2021 | 1535 | 0.160 |
Why?
|
Medulloblastoma | 2 | 2009 | 35 | 0.160 |
Why?
|
Spinal Stenosis | 1 | 2017 | 25 | 0.150 |
Why?
|
von Hippel-Lindau Disease | 1 | 2017 | 17 | 0.150 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2017 | 14 | 0.150 |
Why?
|
Polyethylene | 1 | 2016 | 8 | 0.150 |
Why?
|
Cartilage Diseases | 1 | 2016 | 16 | 0.150 |
Why?
|
Osteolysis | 1 | 2016 | 14 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2015 | 1262 | 0.150 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 418 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 1196 | 0.150 |
Why?
|
Adenoma | 1 | 2019 | 231 | 0.150 |
Why?
|
Signal Transduction | 3 | 2020 | 3198 | 0.150 |
Why?
|
Myeloid-Derived Suppressor Cells | 1 | 2016 | 12 | 0.150 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 375 | 0.150 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2016 | 288 | 0.150 |
Why?
|
Cells, Cultured | 7 | 2020 | 2788 | 0.150 |
Why?
|
Chemokine CCL2 | 1 | 2016 | 47 | 0.150 |
Why?
|
Phosphofructokinases | 1 | 2016 | 2 | 0.150 |
Why?
|
Dendrites | 1 | 2017 | 98 | 0.150 |
Why?
|
Cell Proliferation | 2 | 2020 | 1566 | 0.140 |
Why?
|
Central Nervous System | 1 | 2017 | 151 | 0.140 |
Why?
|
Infant, Newborn | 3 | 2019 | 2336 | 0.140 |
Why?
|
Immunotherapy | 1 | 2021 | 602 | 0.140 |
Why?
|
Prognosis | 6 | 2021 | 3626 | 0.140 |
Why?
|
Spinal Cord Neoplasms | 2 | 2006 | 48 | 0.140 |
Why?
|
Enzyme Inhibitors | 1 | 2019 | 632 | 0.140 |
Why?
|
Myostatin | 1 | 2015 | 3 | 0.140 |
Why?
|
Induction Chemotherapy | 1 | 2016 | 147 | 0.140 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2015 | 13 | 0.140 |
Why?
|
White Matter | 1 | 2016 | 78 | 0.140 |
Why?
|
Meningeal Neoplasms | 1 | 2015 | 57 | 0.140 |
Why?
|
Meningioma | 1 | 2015 | 56 | 0.140 |
Why?
|
Inclusion Bodies | 1 | 2015 | 34 | 0.130 |
Why?
|
Osteoma | 1 | 2014 | 5 | 0.130 |
Why?
|
Aging, Premature | 1 | 2014 | 7 | 0.130 |
Why?
|
Tubulin | 1 | 2015 | 58 | 0.130 |
Why?
|
Hepatitis C | 1 | 2017 | 205 | 0.130 |
Why?
|
Pandemics | 1 | 2021 | 704 | 0.130 |
Why?
|
Protein Transport | 5 | 2019 | 408 | 0.130 |
Why?
|
Femoral Neoplasms | 1 | 2014 | 24 | 0.130 |
Why?
|
Mice, Knockout | 6 | 2019 | 1894 | 0.130 |
Why?
|
Biomarkers | 3 | 2012 | 1671 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 582 | 0.130 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 723 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 645 | 0.130 |
Why?
|
Fluoxetine | 1 | 2014 | 42 | 0.130 |
Why?
|
Adenoma, Oxyphilic | 1 | 2014 | 28 | 0.130 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2014 | 40 | 0.130 |
Why?
|
Mice, Inbred C57BL | 7 | 2017 | 3050 | 0.130 |
Why?
|
Quadriceps Muscle | 1 | 2014 | 5 | 0.130 |
Why?
|
Carbonic Anhydrase IX | 1 | 2014 | 11 | 0.130 |
Why?
|
Neuroprotective Agents | 1 | 2014 | 92 | 0.120 |
Why?
|
Cell Lineage | 1 | 2015 | 265 | 0.120 |
Why?
|
Immunity, Innate | 1 | 2017 | 401 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2015 | 155 | 0.120 |
Why?
|
Caspase 7 | 1 | 2013 | 15 | 0.120 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2013 | 4 | 0.120 |
Why?
|
Caspase 9 | 1 | 2013 | 47 | 0.120 |
Why?
|
Pigmentation | 1 | 2014 | 69 | 0.120 |
Why?
|
Glycerol | 1 | 2013 | 32 | 0.120 |
Why?
|
Radiation | 1 | 2013 | 15 | 0.120 |
Why?
|
Neoplastic Stem Cells | 1 | 2015 | 142 | 0.120 |
Why?
|
Spinal Curvatures | 1 | 2013 | 7 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2014 | 200 | 0.120 |
Why?
|
NIMA-Related Kinases | 1 | 2013 | 7 | 0.120 |
Why?
|
Neurofibroma, Plexiform | 1 | 2013 | 10 | 0.120 |
Why?
|
Caspase 3 | 1 | 2013 | 159 | 0.120 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 275 | 0.120 |
Why?
|
Microscopy, Electron | 3 | 2021 | 500 | 0.120 |
Why?
|
Myasthenia Gravis, Autoimmune, Experimental | 1 | 2012 | 4 | 0.120 |
Why?
|
Dysferlin | 4 | 2015 | 13 | 0.120 |
Why?
|
Recovery of Function | 1 | 2014 | 271 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2013 | 47 | 0.120 |
Why?
|
Calpain | 1 | 2013 | 111 | 0.110 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 545 | 0.110 |
Why?
|
Melanoma | 1 | 2017 | 443 | 0.110 |
Why?
|
Pinealoma | 1 | 2012 | 4 | 0.110 |
Why?
|
Cardiac Myosins | 2 | 2009 | 18 | 0.110 |
Why?
|
Gene Silencing | 2 | 2013 | 172 | 0.110 |
Why?
|
Extremities | 1 | 2013 | 166 | 0.110 |
Why?
|
Motor Activity | 1 | 2014 | 325 | 0.110 |
Why?
|
Kisspeptins | 1 | 2011 | 4 | 0.110 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 175 | 0.110 |
Why?
|
Nanoparticles | 1 | 2013 | 157 | 0.110 |
Why?
|
Intracranial Aneurysm | 1 | 2013 | 158 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2015 | 416 | 0.110 |
Why?
|
Oncogene Proteins | 1 | 2012 | 58 | 0.100 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2012 | 153 | 0.100 |
Why?
|
Gene Amplification | 1 | 2012 | 131 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 684 | 0.100 |
Why?
|
DNA Damage | 1 | 2013 | 361 | 0.100 |
Why?
|
Opsoclonus-Myoclonus Syndrome | 1 | 2011 | 4 | 0.100 |
Why?
|
Choroid Plexus | 1 | 2011 | 14 | 0.100 |
Why?
|
Limbic Encephalitis | 1 | 2011 | 11 | 0.100 |
Why?
|
Superoxide Dismutase | 1 | 2012 | 177 | 0.100 |
Why?
|
Lamin Type A | 1 | 2010 | 23 | 0.100 |
Why?
|
Membrane Fusion | 1 | 2010 | 37 | 0.100 |
Why?
|
Lymphoma, Large-Cell, Immunoblastic | 1 | 2010 | 3 | 0.100 |
Why?
|
Carcinoma, Papillary | 1 | 2012 | 158 | 0.100 |
Why?
|
Radiography | 3 | 2013 | 801 | 0.100 |
Why?
|
Neural Stem Cells | 1 | 2011 | 58 | 0.100 |
Why?
|
Combined Modality Therapy | 3 | 2012 | 1651 | 0.100 |
Why?
|
B-Lymphocytes | 1 | 2015 | 715 | 0.100 |
Why?
|
Guillain-Barre Syndrome | 1 | 2010 | 15 | 0.100 |
Why?
|
NFATC Transcription Factors | 1 | 2010 | 28 | 0.100 |
Why?
|
Hemangioma, Cavernous | 1 | 2011 | 69 | 0.100 |
Why?
|
Peptide Fragments | 2 | 2015 | 459 | 0.100 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 459 | 0.100 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 1363 | 0.100 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2010 | 27 | 0.100 |
Why?
|
Keratins | 2 | 2012 | 63 | 0.100 |
Why?
|
Mediastinal Neoplasms | 1 | 2010 | 45 | 0.090 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 2010 | 54 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 381 | 0.090 |
Why?
|
Receptor, IGF Type 1 | 1 | 2009 | 44 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2011 | 157 | 0.090 |
Why?
|
Homozygote | 2 | 2022 | 200 | 0.090 |
Why?
|
Aging | 1 | 2014 | 675 | 0.090 |
Why?
|
Subarachnoid Space | 1 | 2009 | 17 | 0.090 |
Why?
|
Adenocarcinoma | 1 | 2017 | 1155 | 0.090 |
Why?
|
KATP Channels | 1 | 2009 | 19 | 0.090 |
Why?
|
Age Factors | 3 | 2014 | 1827 | 0.090 |
Why?
|
Lung | 2 | 2021 | 1135 | 0.090 |
Why?
|
Hypertrophy | 2 | 2015 | 62 | 0.090 |
Why?
|
Sarcomeres | 1 | 2009 | 22 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2007 | 290 | 0.090 |
Why?
|
Breast Neoplasms | 2 | 2015 | 2845 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 404 | 0.090 |
Why?
|
Receptors, Drug | 1 | 2009 | 54 | 0.090 |
Why?
|
Brain Infarction | 1 | 2009 | 22 | 0.090 |
Why?
|
Genome, Human | 1 | 2014 | 747 | 0.090 |
Why?
|
Neocortex | 1 | 2010 | 94 | 0.090 |
Why?
|
Cerebral Arteries | 1 | 2009 | 74 | 0.090 |
Why?
|
Exercise Tolerance | 1 | 2009 | 47 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2018 | 455 | 0.090 |
Why?
|
Phenotype | 4 | 2014 | 2347 | 0.090 |
Why?
|
Oligodendroglioma | 1 | 2009 | 44 | 0.090 |
Why?
|
Complement Activation | 1 | 2009 | 80 | 0.090 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 68 | 0.090 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 73 | 0.090 |
Why?
|
Microcirculation | 1 | 2009 | 103 | 0.090 |
Why?
|
Ki-67 Antigen | 1 | 2009 | 60 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2007 | 457 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2018 | 1416 | 0.090 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2009 | 49 | 0.090 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2009 | 141 | 0.090 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2008 | 14 | 0.090 |
Why?
|
Cell Membrane | 2 | 2010 | 660 | 0.090 |
Why?
|
Abnormalities, Multiple | 1 | 2010 | 232 | 0.090 |
Why?
|
Myelitis, Transverse | 1 | 2008 | 10 | 0.090 |
Why?
|
Salivary Glands, Minor | 1 | 2008 | 9 | 0.080 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2009 | 116 | 0.080 |
Why?
|
Submandibular Gland Diseases | 1 | 2008 | 9 | 0.080 |
Why?
|
Electromagnetic Fields | 1 | 2008 | 25 | 0.080 |
Why?
|
Bronchi | 1 | 2009 | 227 | 0.080 |
Why?
|
Neuromyelitis Optica | 1 | 2008 | 21 | 0.080 |
Why?
|
Microscopy, Fluorescence | 3 | 2017 | 420 | 0.080 |
Why?
|
Protein Binding | 4 | 2018 | 1439 | 0.080 |
Why?
|
Ependymoma | 1 | 2007 | 17 | 0.080 |
Why?
|
Caprylates | 1 | 2007 | 11 | 0.080 |
Why?
|
Neural Conduction | 2 | 2010 | 69 | 0.080 |
Why?
|
Fibrosis | 1 | 2008 | 197 | 0.080 |
Why?
|
Pulmonary Artery | 1 | 2009 | 294 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 543 | 0.080 |
Why?
|
Sarcolemma | 3 | 2014 | 30 | 0.080 |
Why?
|
Drug Carriers | 1 | 2008 | 81 | 0.080 |
Why?
|
Head | 1 | 2008 | 130 | 0.080 |
Why?
|
Transplantation, Autologous | 1 | 2008 | 325 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 1 | 2008 | 125 | 0.080 |
Why?
|
Chromosome Mapping | 1 | 2010 | 1069 | 0.080 |
Why?
|
Cell Nucleus | 3 | 2019 | 574 | 0.080 |
Why?
|
Endocytosis | 1 | 2008 | 177 | 0.080 |
Why?
|
Dystrophin | 1 | 2007 | 21 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 2007 | 232 | 0.080 |
Why?
|
Amyloid | 1 | 2007 | 81 | 0.080 |
Why?
|
Arteries | 1 | 2008 | 169 | 0.080 |
Why?
|
Gene Transfer Techniques | 1 | 2007 | 152 | 0.080 |
Why?
|
Action Potentials | 1 | 2010 | 561 | 0.080 |
Why?
|
Epilepsy | 1 | 2010 | 386 | 0.070 |
Why?
|
Antigens, CD | 1 | 2008 | 457 | 0.070 |
Why?
|
Developmental Disabilities | 1 | 2008 | 192 | 0.070 |
Why?
|
Wilms Tumor | 1 | 2006 | 38 | 0.070 |
Why?
|
Muscle Weakness | 2 | 2021 | 61 | 0.070 |
Why?
|
Muscles | 1 | 2007 | 188 | 0.070 |
Why?
|
Chondrocalcinosis | 1 | 2006 | 8 | 0.070 |
Why?
|
Microglia | 2 | 2017 | 96 | 0.070 |
Why?
|
Adenoviridae | 1 | 2007 | 345 | 0.070 |
Why?
|
Synovial Membrane | 1 | 2006 | 27 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2008 | 196 | 0.070 |
Why?
|
Chondrocytes | 1 | 2006 | 59 | 0.070 |
Why?
|
Neurofibroma | 1 | 2005 | 11 | 0.070 |
Why?
|
Heterozygote | 2 | 2018 | 365 | 0.070 |
Why?
|
Single-Blind Method | 1 | 2006 | 156 | 0.070 |
Why?
|
Glycoproteins | 1 | 2007 | 233 | 0.070 |
Why?
|
Age Distribution | 1 | 2006 | 204 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2007 | 207 | 0.070 |
Why?
|
Crystallization | 1 | 2006 | 203 | 0.070 |
Why?
|
Electric Stimulation | 2 | 2020 | 340 | 0.070 |
Why?
|
Tunica Intima | 1 | 2005 | 57 | 0.070 |
Why?
|
Blood Vessels | 1 | 2005 | 94 | 0.070 |
Why?
|
Neovascularization, Physiologic | 1 | 2006 | 131 | 0.070 |
Why?
|
Trans-Activators | 2 | 2005 | 428 | 0.070 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2013 | 131 | 0.070 |
Why?
|
Neuroimmunomodulation | 1 | 2004 | 11 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2007 | 367 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2009 | 376 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2010 | 616 | 0.070 |
Why?
|
Fibroblasts | 3 | 2014 | 723 | 0.060 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 846 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2009 | 660 | 0.060 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 1054 | 0.060 |
Why?
|
Cell Line | 3 | 2019 | 2452 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2010 | 1966 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 668 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 372 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 2329 | 0.060 |
Why?
|
Steroids | 2 | 2018 | 169 | 0.060 |
Why?
|
Gene Knockdown Techniques | 2 | 2015 | 233 | 0.060 |
Why?
|
DNA Methylation | 2 | 2022 | 607 | 0.060 |
Why?
|
Paraparesis | 1 | 2002 | 4 | 0.060 |
Why?
|
Radiculopathy | 1 | 2002 | 15 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2004 | 432 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 2401 | 0.060 |
Why?
|
Homeostasis | 2 | 2018 | 396 | 0.050 |
Why?
|
Cell Movement | 2 | 2016 | 749 | 0.050 |
Why?
|
SOX9 Transcription Factor | 1 | 2022 | 23 | 0.050 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2022 | 50 | 0.050 |
Why?
|
Neurons | 1 | 2010 | 1508 | 0.050 |
Why?
|
Sequence Deletion | 1 | 2022 | 203 | 0.050 |
Why?
|
Patch-Clamp Techniques | 2 | 2014 | 395 | 0.050 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 15 | 0.050 |
Why?
|
Proteins | 1 | 2007 | 762 | 0.050 |
Why?
|
Disease Progression | 3 | 2013 | 1504 | 0.050 |
Why?
|
Models, Molecular | 2 | 2008 | 1276 | 0.050 |
Why?
|
Protein Conformation, beta-Strand | 1 | 2021 | 14 | 0.050 |
Why?
|
Integrin beta3 | 1 | 2021 | 30 | 0.050 |
Why?
|
Protein Aggregates | 1 | 2021 | 20 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2015 | 393 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 128 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2006 | 611 | 0.050 |
Why?
|
Positron Emission Tomography Computed Tomography | 1 | 2021 | 82 | 0.050 |
Why?
|
Femur | 1 | 2021 | 115 | 0.050 |
Why?
|
Molecular Conformation | 1 | 2001 | 95 | 0.050 |
Why?
|
Molecular Weight | 1 | 2001 | 331 | 0.050 |
Why?
|
Phosphenes | 1 | 2020 | 5 | 0.050 |
Why?
|
Hydrogen Bonding | 1 | 2001 | 144 | 0.050 |
Why?
|
In Situ Hybridization | 1 | 2021 | 307 | 0.050 |
Why?
|
Apoptosis | 3 | 2014 | 1669 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 54 | 0.050 |
Why?
|
Conservative Treatment | 1 | 2020 | 20 | 0.050 |
Why?
|
Point Mutation | 1 | 2021 | 246 | 0.050 |
Why?
|
Molecular Structure | 1 | 2001 | 284 | 0.050 |
Why?
|
Risk Assessment | 1 | 2007 | 2230 | 0.050 |
Why?
|
Endosomes | 2 | 2010 | 74 | 0.050 |
Why?
|
Pedigree | 2 | 2014 | 964 | 0.050 |
Why?
|
Ovary | 1 | 2021 | 249 | 0.050 |
Why?
|
Seasons | 1 | 2021 | 221 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2001 | 491 | 0.050 |
Why?
|
Pregnancy, Twin | 1 | 2019 | 7 | 0.050 |
Why?
|
Lysosomes | 2 | 2010 | 103 | 0.050 |
Why?
|
Decompression, Surgical | 1 | 2020 | 87 | 0.050 |
Why?
|
Gene Fusion | 1 | 2019 | 37 | 0.050 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2019 | 25 | 0.050 |
Why?
|
Electrodes, Implanted | 1 | 2020 | 166 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 60 | 0.040 |
Why?
|
Mice, Mutant Strains | 2 | 2009 | 227 | 0.040 |
Why?
|
Nuclear Envelope | 2 | 2009 | 36 | 0.040 |
Why?
|
Twins | 1 | 2019 | 65 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2001 | 481 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2009 | 7829 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2012 | 1204 | 0.040 |
Why?
|
KRIT1 Protein | 1 | 2019 | 62 | 0.040 |
Why?
|
Regeneration | 2 | 2010 | 143 | 0.040 |
Why?
|
Carbonic Anhydrase II | 1 | 2018 | 4 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2019 | 78 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2019 | 169 | 0.040 |
Why?
|
Macrophages | 2 | 2016 | 534 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2018 | 49 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2018 | 69 | 0.040 |
Why?
|
Fetus | 1 | 2019 | 226 | 0.040 |
Why?
|
Synaptic Vesicles | 1 | 2018 | 32 | 0.040 |
Why?
|
Cytoplasm | 1 | 2019 | 278 | 0.040 |
Why?
|
Cytoskeletal Proteins | 2 | 2009 | 221 | 0.040 |
Why?
|
Cryoglobulinemia | 1 | 2017 | 6 | 0.040 |
Why?
|
Muscle Contraction | 1 | 2018 | 283 | 0.040 |
Why?
|
Sural Nerve | 1 | 2017 | 19 | 0.040 |
Why?
|
Time Factors | 3 | 2014 | 5181 | 0.040 |
Why?
|
Tics | 1 | 2017 | 4 | 0.040 |
Why?
|
Cervical Cord | 1 | 2017 | 6 | 0.040 |
Why?
|
Myopia | 1 | 2017 | 10 | 0.040 |
Why?
|
HeLa Cells | 1 | 2018 | 494 | 0.040 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2017 | 16 | 0.040 |
Why?
|
Inhibins | 1 | 2017 | 37 | 0.040 |
Why?
|
Genotype | 2 | 2014 | 1845 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2021 | 500 | 0.040 |
Why?
|
Protein Multimerization | 1 | 2018 | 173 | 0.040 |
Why?
|
Foreign-Body Reaction | 1 | 2016 | 11 | 0.040 |
Why?
|
Thymus Hyperplasia | 1 | 2016 | 3 | 0.040 |
Why?
|
Receptors, CCR4 | 1 | 2016 | 3 | 0.040 |
Why?
|
Melanocytes | 1 | 2017 | 56 | 0.040 |
Why?
|
Arthroplasty, Replacement, Ankle | 1 | 2016 | 17 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2018 | 609 | 0.040 |
Why?
|
Pyramidal Cells | 1 | 2017 | 81 | 0.040 |
Why?
|
Gout | 1 | 2017 | 75 | 0.040 |
Why?
|
Neurodegenerative Diseases | 1 | 2017 | 43 | 0.040 |
Why?
|
Rats | 2 | 2013 | 3968 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 734 | 0.040 |
Why?
|
Face | 1 | 2017 | 120 | 0.040 |
Why?
|
tau Proteins | 1 | 2016 | 58 | 0.040 |
Why?
|
Electroencephalography | 1 | 2020 | 700 | 0.040 |
Why?
|
Prostheses and Implants | 1 | 2016 | 121 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 855 | 0.030 |
Why?
|
Creatine Kinase | 1 | 2015 | 49 | 0.030 |
Why?
|
Follistatin | 1 | 2015 | 7 | 0.030 |
Why?
|
Neurogenesis | 1 | 2016 | 74 | 0.030 |
Why?
|
Immunodominant Epitopes | 1 | 2015 | 19 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2018 | 994 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 77 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 526 | 0.030 |
Why?
|
Ovalbumin | 1 | 2015 | 109 | 0.030 |
Why?
|
NF-kappa B | 1 | 2018 | 435 | 0.030 |
Why?
|
Kyphosis | 1 | 2014 | 12 | 0.030 |
Why?
|
Transgenes | 1 | 2015 | 179 | 0.030 |
Why?
|
Gliosis | 1 | 2014 | 35 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2015 | 97 | 0.030 |
Why?
|
NAV1.5 Voltage-Gated Sodium Channel | 1 | 2014 | 31 | 0.030 |
Why?
|
LIM Domain Proteins | 1 | 2014 | 25 | 0.030 |
Why?
|
Longevity | 1 | 2014 | 46 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 925 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2015 | 232 | 0.030 |
Why?
|
Th1 Cells | 1 | 2015 | 155 | 0.030 |
Why?
|
Caveolin 3 | 1 | 2014 | 4 | 0.030 |
Why?
|
Cellular Senescence | 1 | 2014 | 93 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2015 | 161 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2013 | 12 | 0.030 |
Why?
|
Convection | 1 | 2013 | 12 | 0.030 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2013 | 33 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 868 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 3025 | 0.030 |
Why?
|
Vaccination | 1 | 2015 | 248 | 0.030 |
Why?
|
Algorithms | 2 | 2014 | 1812 | 0.030 |
Why?
|
Ferric Compounds | 1 | 2013 | 37 | 0.030 |
Why?
|
Immunoblotting | 1 | 2013 | 266 | 0.030 |
Why?
|
Bone and Bones | 1 | 2014 | 263 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2014 | 259 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2014 | 362 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2014 | 263 | 0.030 |
Why?
|
Histones | 1 | 2014 | 298 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2014 | 186 | 0.030 |
Why?
|
Superoxide Dismutase-1 | 1 | 2012 | 48 | 0.030 |
Why?
|
S100 Proteins | 1 | 2012 | 50 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 588 | 0.030 |
Why?
|
Up-Regulation | 1 | 2015 | 709 | 0.030 |
Why?
|
RNA Interference | 1 | 2013 | 363 | 0.030 |
Why?
|
Polymers | 1 | 2013 | 198 | 0.030 |
Why?
|
Phosphorylation | 1 | 2014 | 1094 | 0.030 |
Why?
|
N-Myc Proto-Oncogene Protein | 1 | 2012 | 36 | 0.030 |
Why?
|
Cell Division | 1 | 2013 | 696 | 0.030 |
Why?
|
Rabbits | 1 | 2012 | 635 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2015 | 534 | 0.030 |
Why?
|
Cytoplasmic Vesicles | 1 | 2010 | 5 | 0.030 |
Why?
|
Bicuculline | 1 | 2010 | 18 | 0.030 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2010 | 15 | 0.030 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2010 | 39 | 0.030 |
Why?
|
Intracellular Space | 1 | 2010 | 37 | 0.030 |
Why?
|
N-Methylaspartate | 1 | 2010 | 51 | 0.020 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2010 | 45 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2010 | 116 | 0.020 |
Why?
|
Spinal Cord | 1 | 2012 | 241 | 0.020 |
Why?
|
Cell Survival | 1 | 2013 | 967 | 0.020 |
Why?
|
Risk Factors | 1 | 2021 | 5313 | 0.020 |
Why?
|
Electrodiagnosis | 1 | 2010 | 7 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2012 | 448 | 0.020 |
Why?
|
Mice, Inbred mdx | 1 | 2010 | 11 | 0.020 |
Why?
|
Cardiotoxins | 1 | 2010 | 3 | 0.020 |
Why?
|
Pupil | 1 | 2010 | 18 | 0.020 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2010 | 78 | 0.020 |
Why?
|
Muscle Strength | 1 | 2010 | 31 | 0.020 |
Why?
|
Peripheral Nerves | 1 | 2010 | 36 | 0.020 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 4 | 0.020 |
Why?
|
Myoblasts, Skeletal | 1 | 2009 | 3 | 0.020 |
Why?
|
Heterochromatin | 1 | 2009 | 22 | 0.020 |
Why?
|
Neurosurgery | 1 | 2011 | 84 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 348 | 0.020 |
Why?
|
Sulfonylurea Receptors | 1 | 2009 | 48 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2010 | 128 | 0.020 |
Why?
|
Isoenzymes | 1 | 2010 | 270 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 2507 | 0.020 |
Why?
|
Models, Animal | 1 | 2010 | 257 | 0.020 |
Why?
|
Lamins | 1 | 2008 | 6 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 2010 | 984 | 0.020 |
Why?
|
Piperazines | 1 | 2010 | 269 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 542 | 0.020 |
Why?
|
DNA | 1 | 2014 | 1275 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 1594 | 0.020 |
Why?
|
Transferrin | 1 | 2008 | 19 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2010 | 147 | 0.020 |
Why?
|
Hypertension | 1 | 2017 | 1116 | 0.020 |
Why?
|
Cell Fusion | 1 | 2008 | 39 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2008 | 33 | 0.020 |
Why?
|
Macaca fascicularis | 1 | 2008 | 107 | 0.020 |
Why?
|
Sjogren's Syndrome | 1 | 2008 | 29 | 0.020 |
Why?
|
Magnetics | 1 | 2008 | 41 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2009 | 243 | 0.020 |
Why?
|
MicroRNAs | 1 | 2013 | 531 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2009 | 274 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2008 | 114 | 0.020 |
Why?
|
Weight Loss | 1 | 2009 | 227 | 0.020 |
Why?
|
Aldehydes | 1 | 2007 | 17 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2008 | 208 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 334 | 0.020 |
Why?
|
Micelles | 1 | 2007 | 47 | 0.020 |
Why?
|
Pentosyltransferases | 1 | 2007 | 35 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2008 | 350 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 90 | 0.020 |
Why?
|
Asparagine | 1 | 2007 | 29 | 0.020 |
Why?
|
Drug Compounding | 1 | 2008 | 77 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2007 | 64 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2009 | 263 | 0.020 |
Why?
|
Autoantibodies | 1 | 2008 | 257 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2007 | 392 | 0.020 |
Why?
|
Ultrasonography | 1 | 2009 | 674 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2008 | 158 | 0.020 |
Why?
|
Gelsolin | 1 | 2005 | 11 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 2339 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2006 | 130 | 0.020 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 44 | 0.020 |
Why?
|
Mice, Nude | 1 | 2007 | 787 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2005 | 245 | 0.020 |
Why?
|
Parietal Lobe | 1 | 2006 | 117 | 0.020 |
Why?
|
Genetic Therapy | 1 | 2007 | 340 | 0.020 |
Why?
|
Niacinamide | 1 | 2005 | 116 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2005 | 64 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2005 | 111 | 0.020 |
Why?
|
Blood Glucose | 1 | 2009 | 868 | 0.020 |
Why?
|
Genes, Synthetic | 1 | 2004 | 7 | 0.020 |
Why?
|
Lac Operon | 1 | 2004 | 46 | 0.020 |
Why?
|
Doxycycline | 1 | 2004 | 27 | 0.020 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 121 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2004 | 58 | 0.020 |
Why?
|
Cerebellar Ataxia | 1 | 2004 | 19 | 0.020 |
Why?
|
STAT1 Transcription Factor | 1 | 2004 | 51 | 0.020 |
Why?
|
Echocardiography | 1 | 2009 | 895 | 0.020 |
Why?
|
Models, Statistical | 1 | 2008 | 575 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2004 | 90 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 2057 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2004 | 265 | 0.020 |
Why?
|
Prevalence | 1 | 2008 | 1222 | 0.020 |
Why?
|
Astrocytes | 1 | 2004 | 139 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2005 | 204 | 0.020 |
Why?
|
Leukocytes | 1 | 2004 | 201 | 0.020 |
Why?
|
Pyridines | 1 | 2005 | 305 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 159 | 0.010 |
Why?
|
Cerebellum | 1 | 2004 | 241 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 550 | 0.010 |
Why?
|
Stroke | 1 | 2008 | 903 | 0.010 |
Why?
|